Pozemet 15/850mg Tablet

Pozemet 15/850mg Tablet is a combination medication containing two active ingredients: Pioglitazone & Metformin. Pioglitazone belongs to the thiazolidinedione class of drugs, while Metformin is a biguanide antidiabetic agent. This combination tablet is used in the management of type 2 diabetes mellitus to help control blood sugar levels.

Ingredients:

1. Pioglitazone: It improves insulin sensitivity in peripheral tissues, such as muscle and fat cells, and reduces glucose production in the liver.
2. Metformin: It decreases the production of glucose in the liver, increases insulin sensitivity in muscle cells, and reduces intestinal glucose absorption.

Uses:

Pozemet 15/850mg Tablet is prescribed for the treatment of type 2 diabetes mellitus in adults. It helps lower blood sugar levels by improving insulin sensitivity and reducing hepatic glucose production. This medication is typically used along with diet and exercise to achieve better glycemic control.

Administration:

Pozemet 15/850mg Tablet is usually taken orally with meals, as directed by a healthcare professional. The dosage may vary depending on individual factors such as the severity of diabetes and response to treatment. It is important to follow the prescribed dosage instructions provided by the healthcare provider for optimal control of blood sugar levels.

Side Effects:

Common side effects of Pozemet 15/850mg Tablet may include gastrointestinal upset (such as nausea, vomiting, diarrhea, or abdominal discomfort), headache, dizziness, and weight gain. These side effects are usually mild and temporary. However, if they persist or worsen, individuals should consult their healthcare provider. Rare but serious side effects may include lactic acidosis and liver problems.

Precautions:

Before using Pozemet 15/850mg Tablet, individuals should inform their healthcare provider about any pre-existing medical conditions, allergies, or medications they are currently taking. This medication should be used with caution in individuals with kidney impairment, liver disease, heart failure, or a history of lactic acidosis. Regular monitoring of kidney function and liver enzymes may be required during treatment with Pozemet.

Contraindications:

Pozemet 15/850mg Tablet is contraindicated in individuals with a known hypersensitivity or allergy to Pioglitazone, Metformin, or any of the tablet’s components. It should also be avoided in patients with severe kidney impairment, metabolic acidosis, or a history of lactic acidosis. This medication is not recommended for use in patients with type 1 diabetes mellitus or diabetic ketoacidosis.

Conclusion:

Pozemet 15/850mg Tablet, containing Pioglitazone and Metformin, is a combination medication used for the management of type 2 diabetes mellitus in adults. It helps lower blood sugar levels by improving insulin sensitivity and reducing hepatic glucose production. Patients with type 2 diabetes should consult their healthcare provider to determine if Pozemet is an appropriate treatment option for them.